Physician profile
Deen G King
NPI 1861468456
$2,674.93
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $197 · 2021: $385 · 2022: $494 · 2023: $562 · 2024: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $434.57 | 2021-2024 | Acthar |
| Abbvie INC. | $375.64 | 2022-2024 | |
| Ani Pharmaceuticals, INC. | $338.05 | 2023-2024 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $248.79 | 2021-2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $207.37 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $168.99 | 2022-2023 | Vyzulta |
| Allergan, INC. | $167.94 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $161.05 | 2019-2021 | |
| Astellas Pharma US INC | $151.20 | 2023-2024 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.26 | 2019-2021 | |
| Alcon Vision LLC | $97.68 | 2022-2024 | Rocklatan |
| Novartis Pharmaceuticals Corporation | $43.08 | 2019-2021 | |
| Alimera Sciences, INC. | $40.39 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $38.64 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $26.35 | 2023-2024 | Tecnis Iol |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $20.74 | 2023 | Tyrvaya |
| Shire North American Group INC | $18.86 | 2019 | |
| Sight Sciences, INC. | $16.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deen King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.